An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 202832
Company: MEDEFIL INC

Products on NDA 202832

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	9MG/ML (9MG/ML)	INJECTABLE;INJECTION	Discontinued	None	Yes	No
SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	18MG/2ML (9MG/ML)	INJECTABLE;INJECTION	Discontinued	None	Yes	No
SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	22.5MG/2.5ML (9MG/ML)	INJECTABLE;INJECTION	Discontinued	None	Yes	No
SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	27MG/3ML (9MG/ML)	INJECTABLE;INJECTION	Discontinued	None	Yes	No
SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	45MG/5ML (9MG/ML)	INJECTABLE;INJECTION	Discontinued	None	Yes	No
SODIUM CHLORIDE 0.9%	SODIUM CHLORIDE	90MG/10ML (9MG/ML)	INJECTABLE;INJECTION	Prescription	None	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 202832

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/06/2012	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD	Letter (PDF) Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202832_sodiumc_toc.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/26/2022	SUPPL-6	Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202832Orig1s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/202832Orig1s006ltr.pdf
11/29/2017	SUPPL-2	Labeling-Container/Carton Labels	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/202832Orig1s002ltr.pdf
09/27/2012	SUPPL-1	Labeling-Container/Carton Labels, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202832s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/202832Orig1s001ltr.pdf

Labels for NDA 202832

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/26/2022	SUPPL-6	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/202832Orig1s006lbl.pdf
09/27/2012	SUPPL-1	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202832s001lbl.pdf
09/27/2012	SUPPL-1	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202832s001lbl.pdf

Top